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Relationships between changes in time of quality of life and changes
in time of the results of cardiopulmonary exercise test and echocar-
diography at a follow-up of patients with heart failure
Leonidas Athanasopoulos, Athanasios Dritsas, Marianthi Tsakalou, Den-
nis Cokkinos 
Onassis Cardiac Surgery Center, 1st Cardiology, Athens, Grèce
Purpose: Cardiopulmonary exercise testing, echocardiography and plasma
NT-proBNP levels assess patients (pts) with heart failure (HF). Quality of life
(QoL) in HF is measured by Minnesota Living with Heart Failure Question-
naire (MLHF) and Specific Activity Questionnaire (SAQ). It is not known
whether changes in QoL questionnaire scores correlate to changes in the results
of the aforementioned laboratory tests during the follow-up of pts with HF.
Methods: We performed repeat measurements after a median of 26 (21 –
34) months in 30 pts with HF.
They underwent a cardiopulmonary exercise test, an echocardiography test
(LVEF) and a measurement of plasma NT-proBNP. Pts completed MLHF and
SAQ. Changes were calculated in all measures between the first and the
second measurement (Δ). All the patients were taking b-blockers, 83% ACE/
ARBs and 83% diuretics.
Results: Nonsignificant increases were found in peak VO2 (21.47 ± 9.3 to
21.9 ± 4.9 ml/kgr/min; ΔpeakVO2= 1.14 ± 3.5; NS), VE/VCO2 slope (34.47 ±
7 to 35.13 ± 5.1; ΔVE/VCO2= 0.66 ± 5.8; NS), LVEF (32.17 ± 6.27 to 32.48 ±
7.6%; ΔLVEF= 0.16 ± 2.7; NS). NT-proBNP levels decreased nonsignificantly
from a median value of 375.5 pg/ml to 235 pg/ml; median ΔNT-proBNP=-21
pg/ml; NS. SAQ scores improved significantly (6.86 ± 1 to 7.48 ± 1.15; ΔSAQ=
0.625 ± 1.43; p=0.029) and MLHF scores decreased significantly from 21.5 ±
9.3 to 16.6 ± 13 (ΔMLHF= -4.13 ± 9.5; p=0.033). ΔSAQ correlated with
ΔMLHF (r=-0.417, p=0.03) and ΔpeakVO2 (r=0.448, p=0.017). ΔMLHF corre-
lated with ΔLVEF (r=-0.557, p=0.007). ΔVE/VCO2 correlated with ΔpeakVO2
(r=-0.417, p=0.025). ΔNT-proBNP only correlated with ΔpeakVO2 (r=-0.518,
p=0.004) and ΔVE/VCO2 (r=0.538, p=0.003), but with neither questionnaire.
Conclusions: Significant changes in quality of life expressed by MLHF
scores relate to nonsignificant changes in left ventricular ejection fraction,
while significant changes in activity capacity as measured by SAQ relate to
nonsignificant changes in peak oxygen consumption. 
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Both questionnaire scores and laboratory tests can predict hospitali-
zation and death in patients with heart failure
Leonidas Athanasopoulos, Athanasios Dritsas, Dennis Cokkinos 
Onassis Cardiac Surgery Center, 1st Cardiology, Athens, Grèce
Purpose: We compared the prognostic value of quality of life question-
naires, cardiopulmonary exercise testing (CPX), echocardiography, plasma
NT-proBNP in identifying patients (pts) who will be hospitalized for deterio-
ration and/or die from heart failure (HF).
Methods: Sixty-two pts with HF were followed-up for a mean period of
27±7 months for hospitalization for worsening HF and death. They all underwent
a CPX on a treadmill and echocardiography test (LA, LVEF). A measurement of
plasma NT-proBNP was taken and pts completed the Minnesota Living with
Heart Failure Questionnaire (MLHF) and Specific Activity Questionnaire (SAQ).
Results: Two pts (3%) died due to HF and seven pts (11%) were hospital-
ized for worsening HF. The area under the ROC curve (AUC) for NT-proBNP
to identify pts that were hospitalized or died was 0.864; p=0.001. The AUC
for peak VO2, anaerobic threshold and VE/VCO2 slope to identify these pts
was 0.895; p<0.001, 0.853; p=0.001 and 0.922; p<0.001, respectively. LA and
LVEF identified these pts with an AUC: 0.843; p=0.001 and 0.805; p=0.004,
respectively. MLHF and SAQ identified these pts with an AUC: 0.771; p=0.01
and 0.743; p=0.02, respectively. When MLHF score was combined with NT-
proBNP the AUC increased to 0.885; p<0.001.
Conclusion: The best discriminatory power was shown by VE/VCO2
slope. Questionnaire scores had a good discriminatory power, but lower com-
pared to the laboratory measures. The combination of MLHF score with NT-
proBNP, which are easily obtainable, also has a very high prognostic value.
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Relationship between obesity and heart failure with left ventricular
systolic dysfunction
Emanuel Stoica, Ovidiu Chioncel, Andrei Carp, Rodica Stanescu Cioranu,
Ileana Tepes Piser, Iulia Kulcsar, Cezar Macarie
Institut "C.C. Iliescu", Cardiologie, Bucharest, Roumanie
Objective: Assessment of obese patients with heart failure by left ventric-
ular systolic dysfunction (LVEF<40%).
Methods: We included in our study 293 patients with heart failure by left ven-
tricular systolic dysfunction. We analyzed clinical factors (heart failure etiology,
functional class, risk factors – hypertension,dyslipidemia, smoking,diabetes mel-
litus,BMI),electrocardiographic factors (LVH presence,conduction and rhythm
disturbances),echocardiographic features (LVEF,diastolic function, LVH, systolic
PAP) and laboratory data (Hb,serum creatinine,uric acid,WBC count,serum
BNP). Obesity was defined as presence of a BMI>30 kg/m2.
Results: Of the 293 patients included there were 89 obese patients (30.9%)-
73 males (82%) and 16 females(18%).Heart failure was ischemic at 163 patients
(55.6%). At obese patients we observed a more frequent association with hyper-
tension(78.6% of obese patients versus 55.4% nonobese patients;p=0.001); dys-
lipidemia (70.8% of obese patients versus 42.6%;p=0001); diabetes mellitus
(43.8% vs. 14.7%;p=0,0001). Heart failure was more frequent of ischemic eti-
ology at obese patients (66.3% vs. 50.9%; p=0.015). Likewise, EF was greater
at obese patients (32.22 ±6.07% vs. 30.06±6.85%;p=0.011) and sinus rhythm
was more frequent, too(78.6% vs. 67.15%; p = 0,047). There were no significant
differences between BNP at obese and nonobese patients (860.04±803,97 pg/ml
vs. 931.58±881,28 pg/ml;p=0,51,ns),neither between diastolic function,presence
of LVH,QRS duration, enal dysfunction and other factors studied.
Conclusions: A significant proportion of patients with heart failure by left
ventricular systolic dysfunction are obese. At obese patients with heart failure
by left ventricular systolic dysfunction there is a more frequent association
with other risk factors (hypertension, dyslipidemia, diabetes mellitus) and
ischemic etiology of heart failure. BNP values were not significantly different
at obese patients with systolic heart failure versus nonobese patients.
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Epidemiology of chronic heart failure in a Tunisian medical center
Elhem Boussabah, Lilia Zakhama, Ouhoud Yaich, Wassim Bechihi, Sahbi
Gannouchi, Moez Thameur, Soraya Ben Youssef
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Introduction: The prevalence of chronic heart failure (CHF) is increasing
in the world. Coronary artery disease is its most common cause in Europe. In
Tunisia, valvular abnormalities were the leading aetiology of CHF in the
eighties. We sought to determine its epidemiologic profile nowadays.
Methods: 99 patients were hospitalized between 2004 and 2008 for
chronic heart failure in our center. We analysed their demographic features,
clinical caracteristics and their evolution.
Results: The mean age was 59,1± 15 years (24 women). 42 patients were
hypertensive and 42 had diabetes mellitus. 21% had atrial fibrillation. The
mean ejection fraction (EF) at the time of diagnosis was 31,9 ± 8%, 33% of
patients had EF< 30%. Coronary artery disease was the cause in 54% of CHF.
Hypertension was responsible in 16% of cases. A valvulopathy was the aeti-
ology in only 3 cases. At discharge, the ACE were prescribed in 85% of
patients, and betablockers in 41%. The mean follow up was 24 ± 12 months,
12% were in class NYHA III or IV. 50% were hospitalized for worsening HF.
53% of hospitalizations occured during the first 12 months. During the follow
up, 17 patients died, all of cardiac cause (i.e= 11.5%). LVEF was the only
independent predictive factor of morbid-motality.
Conclusion: The epidemiologic profile of CHF in Tunisia had underwent
a profound change during the late decade. The regression of rhumatic fever is
unfortunately opposed by the high prevalence of diabetes mellitus and sys-
temic hypertension in our population which explain this new profile tracing
the european one.
